News
MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held ...
In one of the first major tests of the new FDA leadership’s regulatory philosophy toward gene therapies for rare diseases, ...
15h
MedPage Today on MSNFDA Probes Gene Therapy After Two DeathsThe FDA is investigating the deaths of two boys with Duchenne muscular dystrophy who died soon after being treated with ...
Several ready-to-eat chicken fettuccine alfredo meals sold at Kroger and Walmart are being voluntarily recalled due to a ...
Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.
FDA issues warning letters to companies selling unapproved CBD products. News release. American Veterinary Medical ...
The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene ...
2don MSN
ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...
Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...
Viking Therapeutics announced the start of Phase 3 studies involving its injectable, GLP-1/GIP-targeted obesity drug, called ...
The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results